Home' Australian Pharmacist : Australian Pharmacist May 2013 Contents 6
Australian Pharmacist May 2013 I ©Pharmaceutical Society of Australia Ltd.
PSA and the Royal Australian College
of General Practitioners (RACGP)
strengthened their collaborative efforts
last month when they signed a second
memorandum of understanding (MoU).
The MoU framework focusses on
commitment and cooperation by both
organisations to look at ways of working
together in delivering health services in
the primary healthcare setting to improve
patient health outcomes.
Collectively, the RACGP and the PSA
represent 37,000 primary healthcare
professionals responsible for the Quality
Use of Medicines in Australia.
PSA National President, Grant Kardachi,
said the MoU was an important
development in strengthening
collaboration between GPs
He said the agreement will have a major
impact on improving consumer health
outcomes across Australia.
RACGP President, Dr Liz Marles said,
'we will aim to present a unified voice
in developing policies and solutions
particularly around medication
management that will benefit all patients
and both professions.
Mr Kardachi said, 'the agreement will
develop and foster an ongoing strategic
alliance between both professions
-- an alliance designed to improve
the delivery of health services across
'Our professions have had a long
standing commitment to the quality
use of medicines. Signing of this MoU
reinforces the team-based approach to
primary healthcare, which will further
advance the linkage and collaboration of
health services. It will also strengthen the
communication, liaison and cooperation
between the PSA and RACGP in policy
development, education and training,
media management and advocacy where
there is mutual patient benefit.'
Mr Kardachi said the MoU will also
promote collaborative research
and exchange of information on
specific mutually agreed topics --
'another positive outcome'.
Dr Marles said that, 'this alliance
represents the vast majority of GPs
and pharmacists across Australia and
sees both professions unified as a more
powerful combined voice.
'We welcome this alliance as a great step
forward in a new healthcare environment
where the importance of collaboration,
cooperation and team care are vital in
achieving accessible health services
and improved patient health outcomes,'
PSA and the Pharmacy Guild of
Australia are collaborating to achieving
outcomes in a range of key initiatives
for the profession following a tripartite
meeting with the Department of Health
The Executive Director of the Pharmacy
Guild, David Quilty, and PSA CEO,
Liesel Wett, agreed at the meeting to build
on the cooperative and collaborative work
being done by both groups in a range of
professional and pharmacy practice areas.
One of the key focus areas of the two
organisations will be ensuring that clinical
interventions are delivered and reported
according to the guidelines established
for their delivery. The Guild and PSA
will continue to educate and inform
pharmacists of the clinical interventions
standards and guidelines to ensure the
sustainability of delivery of the service.
They will also work together on
enhancements to the Section 100 Support
Allowance, including by reviewing
and updating the PSA's Guidelines
and Standards on the Provision of
Pharmacy Services to Aboriginal and
Torres Strait Islander Health Services.
This review will draw on expertise in
the respective organisations together
with representatives from other key
stakeholders including the National
Aboriginal Community Controlled Health
The two organisations have also agreed
to work collaboratively on the research
needed to make sure HMR program
targeting is appropriate with this work
also linked to the HMR Hospital Referral
pathway that will commence later year.
Ms Wett said the
collaborative work by
beneficial for the
'The combined resources and input from
the Guild and PSA ensures our approaches
are whole-of-profession and set a
benchmark for future collaborative efforts
in the interests of the whole profession,'
Ms Wett said.
Mr Quilty said: 'It is
we are using our
expertise in these
for the benefit
pharmacy, the pharmacy profession and
patients. This work highlights the need to
ensure that pharmacy programs remain
relevant, sustainable, and focussed on
Dr Liz Marles and Grant Kardachi.
Links Archive Australian Pharmacist April 2013 Australian Pharmacist June 2013 Navigation Previous Page Next Page